Chasing weight loss dream, many in US seek Ozempic alternatives

Dec 4, 2023 | Entertainment, News


In addition to the millions of diabetic and obese patients seeking out drugs like Ozempic, countless others without severe health issues are asking doctors for 'off-label' prescriptions, leading to a major supply crunch
In addition to the millions of diabetic and obese patients seeking out drugs like Ozempic, countless others without severe health issues are asking doctors for ‘off-label’ prescriptions, leading to a major supply crunch.
Photo: Kenzo Tribouillard / AFP
Source: AFP

Like many Americans struggling to lose weight, Marissa Montanino felt compelled to try Ozempic or one of the other new so-called “wonder drugs” described as revolutionary in the fight against obesity.

“I would work out sometimes three times a day, I was doing hours worth of classes. I was eating really, really clean… and nothing was changing” the 36-year-old esthetician told AFP in a recent interview.

“I heard about Ozempic for a while and then you start to see other people doing it like celebrities and then dropping weight super fast,” she said.

Fearing gastrointestinal issues, a side effect of the drugs, Montanino sought reassurance from clients at her studio and in Facebook support groups.

“I was scared. I was super nervous. I am terrified of being nauseous,” she said.

Read also

Maghreb farmers embrace drones to fight climate change

Ultimately deciding to take the leap, Montanino was not prescribed Ozempic, made by Danish drugmaker Novo Nordisk, but rather “compounded” semaglutide.

PAY ATTENTION: Share your outstanding story with our editors! Please reach us through [email protected]!

It’s an option many in the United States are turning to over cost or supply problems with the brand name drugs — but which experts and officials have flagged for possible risks.

Over 40 percent of Americans suffer from obesity, reflecting a major health crisis and the massive market for new Ozempic-type drugs.

With their “groundbreaking” effectiveness, the drugs will be “the first line therapy for people who are obese,” research physician Samuel Klein of Washington University in St. Louis told AFP.

Soaring demand

Semaglutide is the active ingredient in both Ozempic -- approved as a diabetes treatment in 2017 -- and Novo Nordisk's Wegovy, which gained authorization as an obesity medicine in 2021
Semaglutide is the active ingredient in both Ozempic — approved as a diabetes treatment in 2017 — and Novo Nordisk’s Wegovy, which gained authorization as an obesity medicine in 2021.
Photo: MARIO TAMA / GETTY IMAGES NORTH AMERICA/Getty Images via AFP
Source: AFP

Semaglutide is the active ingredient in both Ozempic — approved as a diabetes treatment in 2017 — and Novo Nordisk’s Wegovy, which gained authorization as an obesity medicine in 2021.

Read also

To greenwash or do the right thing? Corporate dilemmas at COP28

In addition to the millions of diabetic and obese patients seeking out the drugs, countless others without severe health issues are asking doctors for “off-label” prescriptions.

Celebrities, including Elon Musk, have also said they take the drugs to shed pounds — fueling skyrocketing interest.

“The major problem is that it is now difficult to get the medications,” said Klein. “There’s not enough medication being made.”

The US Food and Drug Administration (FDA) classifies semaglutide and tirzepatide — the compound used by Eli Lilly in its drugs Mounjaro and Zepbound — as currently “in shortage.”

The designation means some restrictions may be lifted, allowing the compounding of drugs that are “essentially copies of approved drugs,” the FDA says.

Compounding, the creation of custom drugs, has historically been used when a patient has an allergy to a medicine’s component.

Obesity specialist Andrea Coviello told AFP she is concerned about patients taking compounded weight loss drugs, often ordered online.

Read also

With outburst, Musk puts X’s survival in the balance

Though some of her patients who say they’ve tried the compounded drugs lost weight, it’s “unclear what these patients are actually receiving,” the UNC School of Medicine professor and physician said.

Montanino, who is just over five feet (1.53 meters) tall, says that in less than six months using the weekly injections, she has gone down from 157 pounds (71.2 kilograms) to around 130. Her target is 125.

She said that in her group chat with others taking weight loss drugs, only one was on brand name Wegovy, and that “everybody’s super happy.”

‘I’m happier in my skin’

Propelled by growing sales of Ozempic, Denmark-based Novo Nordisk has become Europe's most valuable company and is seeking to rapidly expand its production capacity
Propelled by growing sales of Ozempic, Denmark-based Novo Nordisk has become Europe’s most valuable company and is seeking to rapidly expand its production capacity.
Photo: Sergei GAPON / AFP
Source: AFP

US authorities warn that “compounded drugs pose a higher risk to patients than FDA-approved drugs” because they “do not undergo FDA premarket review for safety, effectiveness, or quality.”

Without further details, it says it has “received adverse event reports after patients used compounded semaglutide.”

An online search for compounded weight loss drugs produces handfuls of retailers offering to ship the medicine by mail.

Read also

After success abroad, Saudi designers hit the runway at home

Advertised prices are much lower than the brand name sticker price, but not necessarily cheaper than when insurance covers it.

Montanino said she initially paid $300 for a three-month supply, but as the dosage increases over time it could eventually become $300 per month.

Given the booming demand for the drugs, it is unclear when they may come off the shortage list.

Already earning billions each quarter on their branded weight-loss medications, Novo Nordisk and Eli Lilly stand to gain even more if they can remove the “shortage” designation, and are ramping up production.

Both have also filed multiple suits against compounding pharmacies, which are making their way through court.

Despite the uncertainty, Montanino said she intends to keep using the drugs, “for life” if possible.

She and her husband, whom she says also lost 50 pounds, celebrated their weight loss by retaking wedding photos on their one-year anniversary.

Read also

“Today is not good at all”: Canada school cancels Nigerian lady’s admission after she quit her job

“I’m happier in my skin. I’m happier with how clothes fit. I hate saying that… But for me, it makes me feel better.”

Source: AFP





Source link

Recent Post

Recent Event Post

Body Doubling for Beginners: The ADHD edition (free event)

Body Doubling for Beginners: The ADHD edition (free event)

Body Doubling for Beginners: The ADHD edition (free event) Get the ultimate 'cheat code' for focus… Experience the power of virtual body doubling to level up your focus and make your ADHD work for you, not against you.  Block out distraction and turn your focus onto a...

Post you may also like

Pin It on Pinterest

Share This
Open chat
1
Scan the code
EventsChronicles
Hello 👋
How can we help you?